Structure Therapeutics Inc.

GPCR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$123-$90-$51-$38
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$19$8$3$1
Change in WC$3$7$3$4
Other Non-Cash-$17-$5-$1$0
Operating Cash Flow-$117-$79-$46-$32
Investing Activities
PP&E Inv.-$1-$2-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$703-$417-$123-$4
Inv. Sales/Matur.$345$151$62$23
Other Inv. Act.$0-$0$0$0
Investing Cash Flow-$359-$268-$62$18
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$515$472$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1-$21$29$103
Financing Cash Flow$515$452$29$103
Forex Effect$0$0$0$0
Net Chg. in Cash$40$104-$79$89
Supplemental Information
Beg. Cash$130$26$105$16
End Cash$170$130$26$105
Free Cash Flow-$118-$82-$46-$33
Structure Therapeutics Inc. (GPCR) Financial Statements & Key Stats | AlphaPilot